Pfost Dale R's Form 4 filing
Chemomab Therapeutics Ltd. (CMMB) · filed Mar 15, 2022
- Accession no.
- 0001178913-22-001120
- Filed
- Mar 15, 2022
- Trade date
- Oct 25, 2021-Mar 14, 2022
- Filing delay
- 141 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market purchases total $9.94K. It was filed 141 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pfost Dale RCIK 0001394663 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2022 | American Depositary Shares | PPurchaseAcquired | +1,800 | $3.98 | +$7,164 | 1,800 | Direct | |
| Mar 14, 2022 | American Depositary Shares | PPurchaseAcquired | +700 | $3.97 | +$2,779 | 2,500 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 25, 2021 | American Depositary Shares | AGrant or awardAcquired | +459,353 | $0.00 | $0 | 459,353 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.